Trial intelligence / Profile preview

Intravenous dexamethasone dose comparison for postoperative pain and sleep quality after total knee arthroplasty

IRCT20230316057742N1Phase 3Completed

Sponsor
Babol University of Medical Sciences
Start
Mar 2023
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of dexamethasone in postoperative pain and sleep disorder (3 arms), sponsored by Babol University of Medical Sciences. Primary endpoints: Pain level and Sleep quality. Started Mar 2023; status: completed.

02

Drugs

dexamethasone
03

Conditions

postoperative painsleep disorder

Beyond the preview

Go deeper on IRCT20230316057742N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20230316057742N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call